GoKawiilStudy links BACH2 and NRF2 genes to fetal haemoglobin regulation
Researchers combined genome-wide association data from multiple cohorts—including general population groups and sickle cell disease patients from Tanzania, Brazil, the US and Thailand—to study genetic variants influencing fetal haemoglobin (HbF) levels. The analysis identified a BACH2–NRF2 gene axis as implicated in activating fetal haemoglobin production, drawing on differing study designs across ancestries and disease status.
GoKawiil's interpretation of the reporting above, not reported fact.
Fetal haemoglobin can substitute for adult haemoglobin in blood disorders like sickle cell disease and thalassaemia, so genes that control its levels are of therapeutic interest. Identifying the BACH2–NRF2 pathway could point toward new drug targets or gene-editing strategies aimed at reactivating fetal haemoglobin in patients, though this would require further validation beyond the genetic association reported here.
- Meta-analysis pooled GWAS data from diverse cohorts spanning European, African and Thai ancestries
- A BACH2–NRF2 gene axis was implicated in regulating fetal haemoglobin levels
- Findings could inform future therapeutic approaches for sickle cell disease and thalassaemia, pending further research
Source: nature.com — Guo, 2026-09-30
Published there as: “Human genetics implicates a BACH2–NRF2 axis in fetal haemoglobin activation”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.